621 related articles for article (PubMed ID: 15663510)
21. Strong family history of uterine leiomyomatosis warrants fumarate hydratase mutation screening.
Tolvanen J; Uimari O; Ryynänen M; Aaltonen LA; Vahteristo P
Hum Reprod; 2012 Jun; 27(6):1865-9. PubMed ID: 22473397
[TBL] [Abstract][Full Text] [Related]
22. [From gene to disease; cutaneous leiomyomatosis].
Badeloe S; van Geel M; van Steensel MA; Steijlen PM; Poblete-Gutiérrez P; Frank JA
Ned Tijdschr Geneeskd; 2007 Feb; 151(5):300-4. PubMed ID: 17326474
[TBL] [Abstract][Full Text] [Related]
23. Clinical and molecular genetic aspects of hereditary multiple cutaneous leiomyomatosis.
Badeloe S; Frank J
Eur J Dermatol; 2009; 19(6):545-51. PubMed ID: 19939761
[TBL] [Abstract][Full Text] [Related]
24. Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma.
Gardie B; Remenieras A; Kattygnarath D; Bombled J; Lefèvre S; Perrier-Trudova V; Rustin P; Barrois M; Slama A; Avril MF; Bessis D; Caron O; Caux F; Collignon P; Coupier I; Cremin C; Dollfus H; Dugast C; Escudier B; Faivre L; Field M; Gilbert-Dussardier B; Janin N; Leport Y; Leroux D; Lipsker D; Malthieu F; McGilliwray B; Maugard C; Méjean A; Mortemousque I; Plessis G; Poppe B; Pruvost-Balland C; Rooker S; Roume J; Soufir N; Steinraths M; Tan MH; Théodore C; Thomas L; Vabres P; Van Glabeke E; Meric JB; Verkarre V; Lenoir G; Joulin V; Deveaux S; Cusin V; Feunteun J; Teh BT; Bressac-de Paillerets B; Richard S;
J Med Genet; 2011 Apr; 48(4):226-34. PubMed ID: 21398687
[TBL] [Abstract][Full Text] [Related]
25. Novel Fumarate Hydratase Mutation in Siblings With Early Onset Uterine Leiomyomas and Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome.
Gunnala V; Pereira N; Irani M; Lilienthal D; Pirog EC; Soslow R; Caputo TA; Elias R; Kligman I; Rosenwaks Z
Int J Gynecol Pathol; 2018 May; 37(3):256-261. PubMed ID: 28700432
[TBL] [Abstract][Full Text] [Related]
26. Mutation screening of fumarate hydratase by multiplex ligation-dependent probe amplification: detection of exonic deletion in a patient with leiomyomatosis and renal cell cancer.
Ahvenainen T; Lehtonen HJ; Lehtonen R; Vahteristo P; Aittomäki K; Baynam G; Dommering C; Eng C; Gruber SB; Grönberg H; Harvima R; Herva R; Hietala M; Kujala M; Kääriäinen H; Sunde L; Vierimaa O; Pollard PJ; Tomlinson IP; Björck E; Aaltonen LA; Launonen V
Cancer Genet Cytogenet; 2008 Jun; 183(2):83-8. PubMed ID: 18503824
[TBL] [Abstract][Full Text] [Related]
27. Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndrome.
Alam NA; Barclay E; Rowan AJ; Tyrer JP; Calonje E; Manek S; Kelsell D; Leigh I; Olpin S; Tomlinson IP
Arch Dermatol; 2005 Feb; 141(2):199-206. PubMed ID: 15724016
[TBL] [Abstract][Full Text] [Related]
28. Fumarate Hydratase Mutation in a Young Woman With Uterine Leiomyomas and a Family History of Renal Cell Cancer.
Mann ML; Ezzati M; Tarnawa ED; Carr BR
Obstet Gynecol; 2015 Jul; 126(1):90-2. PubMed ID: 25923021
[TBL] [Abstract][Full Text] [Related]
29. A case report of hereditary leiomyomatosis and renal cell cancer.
Frey MK; Worley MJ; Heyman KP; Caputo TA
Am J Obstet Gynecol; 2010 Jun; 202(6):e8-9. PubMed ID: 20510956
[TBL] [Abstract][Full Text] [Related]
30. [Multiple familial cutaneous leiomyoma].
Cairey-Remonnay S; Salard D; Algros MP; Laurent R
Ann Dermatol Venereol; 2003 Nov; 130(11):1017-20. PubMed ID: 14724535
[TBL] [Abstract][Full Text] [Related]
31. Germline fumarate hydratase mutations in families with multiple cutaneous and uterine leiomyomata.
Martinez-Mir A; Glaser B; Chuang GS; Horev L; Waldman A; Engler DE; Gordon D; Spelman LJ; Hatzibougias I; Green J; Christiano AM; Zlotogorski A
J Invest Dermatol; 2003 Oct; 121(4):741-4. PubMed ID: 14632190
[TBL] [Abstract][Full Text] [Related]
32. [Familial cutaneous leiomyomas and their association with uterine myoma. Study of a 3-generation pedigree].
Valdivia L; Temiño MA; Tuñon M; Sandoval C; Quintanilla E
Med Cutan Ibero Lat Am; 1983; 11(2):133-8. PubMed ID: 6350755
[TBL] [Abstract][Full Text] [Related]
33. No evidence for epigenetic inactivation of fumarate hydratase in leiomyomas and leiomyosarcomas.
Barker KT; Spendlove HE; Banu NS; Bridge JA; Fisher C; Shipley J; Garrett M; Manyonda I; Houlston RS
Cancer Lett; 2006 Apr; 235(1):136-40. PubMed ID: 15949892
[TBL] [Abstract][Full Text] [Related]
34. Evidence for a new fumarate hydratase gene mutation in a unilateral type 2 segmental leiomyomatosis.
Parmentier L; Tomlinson I; Happle R; Borradori L
Dermatology; 2010; 221(2):149-53. PubMed ID: 20628236
[TBL] [Abstract][Full Text] [Related]
35. [Familial occurrence of a type 2 segmental manifestation of cutaneous leiomyomatosis].
Renner R; Sticherling M
J Dtsch Dermatol Ges; 2005 Sep; 3(9):695-9. PubMed ID: 16173977
[TBL] [Abstract][Full Text] [Related]
36. Germline fumarate hydratase mutations in patients with ovarian mucinous cystadenoma.
Ylisaukko-oja SK; Cybulski C; Lehtonen R; Kiuru M; Matyjasik J; Szymañska A; Szymañska-Pasternak J; Dyrskjot L; Butzow R; Orntoft TF; Launonen V; Lubiñski J; Aaltonen LA
Eur J Hum Genet; 2006 Jul; 14(7):880-3. PubMed ID: 16639410
[TBL] [Abstract][Full Text] [Related]
37. Novel FH mutation in a patient with cutaneous leiomyomatosis associated with cutis verticis gyrata, eruptive collagenoma and Charcot-Marie-Tooth disease.
Marque M; Gardie B; Bressac de Paillerets B; Rustin P; Guillot B; Richard S; Bessis D
Br J Dermatol; 2010 Dec; 163(6):1337-9. PubMed ID: 20560959
[TBL] [Abstract][Full Text] [Related]
38. Familial cutaneous and uterine leiomyomas: case report.
Cisło M; Szepietowski F; Wasik JC; Maj J; Hryncewicz-Gwózdz A; Nockowski P
Acta Dermatovenerol Croat; 2003 Dec; 11(4):212-6. PubMed ID: 14670220
[TBL] [Abstract][Full Text] [Related]
39. No germline FH mutations in familial breast cancer patients.
Kiuru M; Lehtonen R; Eerola H; Aittomäki K; Blomqvist C; Nevanlinna H; Aaltonen LA; Launonen V
Eur J Hum Genet; 2005 Apr; 13(4):506-9. PubMed ID: 15523491
[TBL] [Abstract][Full Text] [Related]
40. Hereditary leiomyomatosis and renal cell cancer: an unusual and aggressive form of hereditary renal carcinoma.
Refae MA; Wong N; Patenaude F; Bégin LR; Foulkes WD
Nat Clin Pract Oncol; 2007 Apr; 4(4):256-61. PubMed ID: 17392716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
